#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14052	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2490	694.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1595	1595	C	804	C,G	803,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14052	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2490	694.1	0	HET	.	.	.	C207T	.	207	207	C	618	618	C	857	C,T	703,154	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23682	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3981	741.7	0	.	n	.	0	T695C	SNP	695	695	T	1252	1252	C	894	C,T,G	892,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23682	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3981	741.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	2195	2195	G	863	G,A	862,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23682	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3981	741.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2528	2528	C	822	C	822	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23682	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3981	741.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2602	2602	A	744	A	744	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23682	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3981	741.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3154	3154	C	861	C,A	860,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23682	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3981	741.7	0	HET	.	.	.	G2680A	.	2680	2680	G	3237	3237	G	859	G,A	656,203	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1762	folP	852	852	99.77	folP.l15.c4.ctg.1	2126	103.5	0	.	p	.	0	S68P	NONSYN	202	204	TCG	870	872	CCG	157;158;159	C;C,A;G,C	157;157,1;157,2	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1762	folP	852	852	99.77	folP.l15.c4.ctg.1	2126	103.5	0	.	p	.	0	A204V	NONSYN	610	612	GCA	1278	1280	GTA	175;178;180	G;T,G;A	175;177,1;180	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1762	folP	852	852	99.77	folP.l15.c4.ctg.1	2126	103.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1350	1352	AGC	171;175;175	A,T;G;C	170,1;175;175	folP.WHO_X_01360c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4550	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3855	147.4	1	SNP	p	S91F	1	.	.	271	273	TTC	776	778	TTC	192;194;195	T,C;T;C	191,1;194;195	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4550	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3855	147.4	1	SNP	p	G95N	0	.	.	283	285	GGC	788	790	GGC	198;199;201	G;G;C	198;199;201	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4550	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3855	147.4	1	SNP	p	D95G	1	.	.	283	285	GGC	788	790	GGC	198;199;201	G;G;C	198;199;201	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1676	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1724	121.1	1	SNP	p	G45D	0	.	.	133	135	GGC	697	699	GGC	188;188;187	G;G;C	188;188;187	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	868	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1419	76.2	0	.	n	.	0	A197.	DEL	197	197	A	742	742	A	171	A	171	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5168	parC	2304	2304	100.0	parC.l6.c17.ctg.1	3366	191.6	1	SNP	p	D86N	0	.	.	256	258	GAC	789	791	GAC	228;228;225	G;A,G;C	228;227,1;225	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5168	parC	2304	2304	100.0	parC.l6.c17.ctg.1	3366	191.6	1	SNP	p	S87R	1	.	.	259	261	CGT	792	794	CGT	223;222;222	C;G;T,C	223;222;221,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5168	parC	2304	2304	100.0	parC.l6.c17.ctg.1	3366	191.6	1	SNP	p	R87W	0	.	.	259	261	CGT	792	794	CGT	223;222;222	C;G;T,C	223;222;221,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5168	parC	2304	2304	100.0	parC.l6.c17.ctg.1	3366	191.6	1	SNP	p	R87I	0	.	.	259	261	CGT	792	794	CGT	223;222;222	C;G;T,C	223;222;221,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5168	parC	2304	2304	100.0	parC.l6.c17.ctg.1	3366	191.6	1	SNP	p	S88P	0	.	.	262	264	TCC	795	797	TCC	221;221;221	T;C;C	221;221;221	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3494	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3048	142.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1738	1740	GGC	204;202;202	G;G;C	204;202;202	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3776	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2895	162.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1481	1483	GCC	220;220;219	G;C,T;C	220;218,2;219	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3776	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2895	162.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1484	1486	ATG	217;218;222	A;T;G	217;218;222	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3776	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2895	162.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1496	1498	ACC	228;232;232	A;C;C,G	228;232;231,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3776	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2895	162.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1496	1498	ACC	228;232;232	A;C;C,G	228;232;231,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3776	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2895	162.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1997	1999	ACC	228;225;223	A;C,A;C	228;224,1;223	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3776	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2895	162.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2051	2053	GCG	186;189;190	G;C;G	186;189;190	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3776	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2895	162.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2051	2053	GCG	186;189;190	G;C;G	186;189;190	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3776	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2895	162.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2174	2176	GGT	231;231;227	G;G;T,C	231;231;226,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3776	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2895	162.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2183	2185	AGC	224;226;226	A,G;G,T;C	223,1;225,1;226	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3776	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2895	162.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2201	2203	CCG	220;223;222	C,G;C,T;G,C	219,1;222,1;221,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5516	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3461	198.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1785	1787	CCG	226;226;227	C,G;C;G	225,1;226;227	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2390	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2439	122.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	953	953	C	204	C	204	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3030	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	2189	172.7	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1225	1227	AGA	256;257;257	A;G;A	256;257;257	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3030	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	2189	172.7	1	SNP	p	G120K	1	.	.	358	360	AAG	955	957	AAG	267;267;267	A;A;G,C,A	267;267;265,1,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3030	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	2189	172.7	1	SNP	p	N121D	0	.	.	361	363	AAC	958	960	AAC	267;269;269	A;A;C	267;269;269	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3030	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	2189	172.7	1	SNP	p	A121N	1	.	.	361	363	AAC	958	960	AAC	267;269;269	A;A;C	267;269;269	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10082	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5266	239.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1408	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1317	132.5	1	SNP	p	V57M	1	.	.	169	171	ATG	690	692	ATG	232;231;230	A,T;T,C;G	231,1;230,1;230	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
